Automatic pill dispenser machines are designed to ease the work load of pharmacist, doctor, nurse, patients, and caretakers, by enabling medication counting, medicine management, and dispensing and inventory control. These devices support minimization of prescription errors that lead to fatal injury or death and ensure patient safety. The global automatic pill dispenser machine market accounted for $1,755 million in 2016, and is estimated to reach $3,023 million by 2023, growing at a CAGR of 8% during the analysis period of 2017-2023.
Increase in healthcare awareness, rapid growth of infections & chronic diseases such as diabetes, asthma, blood pressure, & others, and a rise in the geriatric population primarily drive the automatic pill dispenser machine market. The rise in need for self-care and home-based treatments due to hectic lifestyles and to reduce prescription & dispensing errors fuel the market growth. Furthermore, growth in healthcare expenditure and technological advancement for workflow optimization in hospitals and other healthcare centers drive the market growth. However, high installation cost of some of these systems and significant levels of government rules & regulations associated with production and sale of automatic pill dispenser machine limit the growth of the market. Ongoing R&D in the field of automatic pill dispenser machine is anticipated to create new opportunities during the forecast period.
The market is segmented on the basis of type, application, and region. Based on type, the market is categorized into centralized automated dispensing systems and decentralized automated dispensing systems. Based on application, the market is classified into hospital pharmacy, retail pharmacy, and home healthcare. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
KEY PLAYERS PROFILED
KEY MARKET SEGMENTS
The other players operating in the automatic pill dispenser machine market include (companies not profiled in the report):
Cephalosporin Market by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, and Fifth-generation), Type (Branded and Generics), Route of Drug Administration (Injection and Oral), and Application (Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, and Sexually Transmitted Infection) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep ...
November 2017 | $5370 |View Details>>
The Global Drugs for Malaria market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Drugs for Malaria market, especially in North America, Europe, Asia-Pacific, South ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Drugs for Malaria market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Drugs for Malaria in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and ...
November 2017 | $4660 |View Details>>
In 2016, the Drugs for Malaria market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include Cipla Guilin Pharmaceutical ...
November 2017 | $3360 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research